EDITION:
Celadon Pharmaceuticals Celadon Pharmaceuticals has seen its stock price spike this week after revealing that its supply agreement with
Poland has seen the number of medical cannabis prescriptions plummet since it moved to crack down on telemedicine prescriptions. Telemedicine
The Czech Republic is continuing to make progress on an ambitious overhaul of its drug policies, with sweeping reforms aimed at creating a regulated market for low-risk psychoactive substances and addressing long-standing issues in medical cannabis access.
Today’s visit by Prime Minister Michael Kretschmer, part of the CDU, a party known for its critical stance on cannabis, to Grünhorn in Leipzig marks a significant milestone in the political recognition of cannabis as a plant-based medicine.
This story was first reported on Cannabis Health News. Hundreds of families in the UK are giving their children
The UK Government is being sued by a CBD business for £3.4m, in the latest major challenge to its mishandling of legal hemp.
Ahead of the release of Prohibition Partners upcoming Global Cannabis Report: 5th Edition, we sat down with Sebastian Zeller, Managing
Cantourage Berlin-based medical cannabis company Cantourage saw sales exceed its own projections in 2024, with sales more than
The first medical cannabis products have officially been registered in Ukraine, meaning patients should be able to access treatment in the coming weeks.
SOMAÍ Pharmaceuticals, a leading EU-GMP vertically integrated Multi-Country Operator (MCO) with the most advanced cannabinoid pharmaceutical extract portfolio, has partnered
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
